1. Home
  2. IMRX vs ACR Comparison

IMRX vs ACR Comparison

Compare IMRX & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • ACR
  • Stock Information
  • Founded
  • IMRX 2008
  • ACR 2005
  • Country
  • IMRX United States
  • ACR United States
  • Employees
  • IMRX N/A
  • ACR N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • ACR Real Estate Investment Trusts
  • Sector
  • IMRX Health Care
  • ACR Real Estate
  • Exchange
  • IMRX Nasdaq
  • ACR Nasdaq
  • Market Cap
  • IMRX 145.7M
  • ACR 139.0M
  • IPO Year
  • IMRX 2021
  • ACR N/A
  • Fundamental
  • Price
  • IMRX $3.52
  • ACR $19.58
  • Analyst Decision
  • IMRX Strong Buy
  • ACR Buy
  • Analyst Count
  • IMRX 4
  • ACR 2
  • Target Price
  • IMRX $13.25
  • ACR $17.50
  • AVG Volume (30 Days)
  • IMRX 486.1K
  • ACR 27.0K
  • Earning Date
  • IMRX 08-19-2025
  • ACR 07-30-2025
  • Dividend Yield
  • IMRX N/A
  • ACR N/A
  • EPS Growth
  • IMRX N/A
  • ACR N/A
  • EPS
  • IMRX N/A
  • ACR 0.04
  • Revenue
  • IMRX N/A
  • ACR $86,599,000.00
  • Revenue This Year
  • IMRX N/A
  • ACR $3.57
  • Revenue Next Year
  • IMRX N/A
  • ACR N/A
  • P/E Ratio
  • IMRX N/A
  • ACR $415.94
  • Revenue Growth
  • IMRX N/A
  • ACR 12.74
  • 52 Week Low
  • IMRX $1.00
  • ACR $14.87
  • 52 Week High
  • IMRX $4.69
  • ACR $23.81
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 47.82
  • ACR 64.99
  • Support Level
  • IMRX $3.25
  • ACR $18.93
  • Resistance Level
  • IMRX $4.69
  • ACR $19.78
  • Average True Range (ATR)
  • IMRX 0.28
  • ACR 0.49
  • MACD
  • IMRX -0.13
  • ACR 0.12
  • Stochastic Oscillator
  • IMRX 18.76
  • ACR 92.78

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

Share on Social Networks: